Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome
about
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsThe role of endogenous gastrin in the development of enterochromaffin-like cell carcinoid tumors in Mastomys natalensis: a study with the specific gastrin receptor antagonist AG-041RRole of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.Unusual gastric tumors and tumor-like lesions: Radiological with pathological correlation and literature review.Pathogenesis of ECL cell tumors in humans.Diagnosis and treatment of ECL cell tumors.Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.Oxyntic endocrine cells of hypergastrinaemic patients. Differential response to antrectomy or octreotide.Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literatureResolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.Treatment of Zollinger-Ellison syndrome.A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factorsZollinger-Ellison syndrome: past, present and future controversies.CCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disordersDiagnosis and Treatment of Gastrinomas in Multiple Endocrine Neoplasia Type 1 (MEN-1).Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.Care for patients with multiple endocrine neoplasia type 1: the current evidence base.ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms.Review article: the investigation and management of gastric neuroendocrine tumours.Gastric neuroendocrine neoplasms and related precursor lesions.Republished: gastric neuroendocrine neoplasms and related precursor lesions.Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome.Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?Gastrin receptor gene expression in several human carcinomas.Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1.Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.Proton pump inhibitors on pancreatic cancer risk and survival.Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumours
P2860
Q24647838-6C27F5DB-A013-4E7A-B21E-D6307FBBE6D9Q28290833-44A60AEF-0FD5-4522-AB0E-1A275EA55268Q28343536-6AEC7E68-CE90-4426-A94F-EFBC0E411F4EQ30487910-91E66282-9B33-4864-ACE7-BB3C9E107CB3Q33572638-D659EDF6-83EA-4479-B165-3E3CFBAB7BBCQ33719575-33517D57-C885-4B36-970B-D429FF2D4492Q33719585-874334EF-BF19-4686-A731-1D17128D9FD6Q34181922-A470B48C-84AA-4577-8403-52B3066E228DQ34409661-744EB56E-1FCB-42E7-8DAF-D35BF0AD5DAAQ35851346-5C0AC310-5101-4CA1-A1DC-A74BA4D63D3BQ35922060-4FE40177-B916-4576-B5BC-02C9CBF2A066Q36285347-AB7A0B9F-F05A-4927-B8DE-3552C5D0ADC3Q36661917-EDF6AD7B-E2D7-4510-8C66-136DEA956BA8Q36987493-66FFAED1-DC3B-4B84-8F0F-4447336514BEQ36987633-3C1D7638-360B-468B-90E0-036DB75E28FAQ37016985-43ABE138-EB43-45AC-A6F4-2D0A581C033FQ37017018-F50FF872-C930-415E-9F9D-27B30186962AQ37056120-D4F6F9F8-3EEA-42B9-9378-CB96B1A0AAA1Q37113534-07FABDB3-2411-4507-805A-AD86541493CCQ37808142-29C1093A-502B-4D48-B182-5468D815E50BQ37977330-57AFC766-8FEF-4A18-A56A-1513622F34CEQ38195905-6173EB13-0865-4D79-89D2-76C4049A4C35Q38232979-761056D4-6AD6-4BF4-B123-A14D8F8C6ABEQ38367729-EF418767-CF1C-431D-B4D0-755124E816CBQ40821939-3091097F-D1D8-48DC-A289-862EF1F05E4FQ40852115-E0F283F2-4835-4E58-AADF-254CF33F1DE5Q41452161-6CD36DC6-7B24-4C74-88D4-D05B01F4BEC8Q42458826-C54BF8FE-B2E2-4884-A71C-646844E13225Q44080567-2F795152-F8DE-4BCE-859B-9B4A3F260145Q50970848-1C6DB58B-B0C1-454F-AB40-EB0A1B93CDA0Q51564397-6E537C97-F7B1-4897-BBD2-440C7C56A2CAQ55981792-6FFCC26D-7E85-4653-A8B1-D5238331E459
P2860
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@ast
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@en
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@nl
type
label
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@ast
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@en
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@nl
prefLabel
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@ast
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@en
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@nl
P2093
P2860
P356
P1433
P1476
Influence of multiple endocrin ...... the Zollinger-Ellison syndrome
@en
P2093
P2860
P304
P356
10.1136/GUT.33.9.1275
P407
P577
1992-09-01T00:00:00Z